C-Suite Survey Underscores Digital Technology’s Growing Role in Clinical Trials

COVID-19 has been a change agent in four areas of the biopharma industry: digital technology, artificial intelligence (AI) and machine learning, regulation, and real-world evidence. In this two-part survey, the impact of the pandemic and its substantial influence on biopharma executives’ expectations in these areas is apparent.